Diabetic Retinopathy

ADA lowers optimal blood sugar levels for kids

The recommendation was published in Diabetes Care in a review article by Dr. Maria J. Redondo, a pediatric endocrinologist at Texas Children's Hospital and professor at Baylor College of Medicine, as well as Dr. Sarah Lyons, pediatric endocrinologist at Texas Children's and assistant professor at Baylor College of Medicine.

January 14, 2021

Google's deep learning outperforms general pathologists in prostate biopsies

The research comes from a deep-learning/artificial intelligence (AI) research team at Google Health in Palo Alto, CA. For the study, performance of the deep-learning system and general pathologists were compared to assessment by a panel of urologic subspecialist pathologists for the evaluation of prostate cancer needle core biopsy formalin-fixed paraffin-embedded (FFPE) specimens.

July 23, 2020

Smartphones double as point-of-care diagnostics

The technical capabilities of these phones have become so advanced that they can compete with technology once thought to be only the domain of physicians' offices and hospitals. Research groups and startup companies are developing apps and technology that turn smartphones into tools that can diagnose eye disease, perform home-based urinalysis, diagnose ear infections and respiratory disease, and help women learn about their reproductive health.

December 1, 2019

Blood test spots diabetes complications early on

The development is significant for patients with type 2 diabetes because if vascular complications, such as heart disease, atherosclerosis, or kidney failure, are detected at an early stage, preventive treatments could be given to avoid severe clinical outcomes down the line.

October 1, 2019

Most Popular

Quest launches long-COVID testing panels for consumers

SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests

Duke University researchers discover biomarkers may identify early pancreatic cancer risk

FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay

LumiraDx Q4 revenues drop 65% on lower COVID-19 testing

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux